Tumescent anesthesia for reducing pain, swelling, and ecchymosis during polycaprolactone filler injections in the face

被引:7
作者
Kim, JongSeo [1 ]
机构
[1] Kim JongSeo Plast Surg Clin, 842 NonHyun Ro, Seoul, South Korea
关键词
Swelling; eccymosis; PCL filler; injection method;
D O I
10.1080/14764172.2017.1342037
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
PCL filler can be injected in two major ways to control pain. One such method involves mixing 0.3cc of PCL filler with lidocaine, and the other is the method introduced in this report, which involves pre-injection with a tumescent solution. It is hard to reduce pain effectively with pre-mixing PCL filler with lidocaine because there may be not enough time to act lidocaine solution effect immediately for pain control. The pre-mixing method changes the properties of the original filler, especially the property of the CMC portion. Therefore, in my simple and novel technique, tumescent solution is injected, followed by PCL filler which preserves the original CMC property. This is done after sedation of the tissue by the tumescent solution and dissection of soft tissue to create a space for the ensuing PCL injection. After pre-injection with tumescent solution, histological analysis indicated that the tissue did not become irritated in response to the foreign body material (PCL filler) or the mechanical trauma caused by the needle. That is the key mechanism of the tumescent injection method for reducing tissue reaction and that may reduce pain and swelling during and after PCL filler injections.
引用
收藏
页码:434 / 438
页数:5
相关论文
共 6 条
[1]   Investigation of physical properties of a polycaprolactone dermal filler when mixed with lidocaine and lidocaine/epinephrine [J].
Francisco de Melo ;
Joanna Marijnissen-Hofsté .
Dermatology and Therapy, 2012, 2 (1) :1-10
[2]   Fillers: From the Past to the Future [J].
Glogau, Richard G. .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2012, 31 (02) :78-87
[3]  
Kim Jin-Ung, 2014, Journal of Fish Pathology, V27, P1
[4]  
Loghem Jani Van, 2015, J Clin Aesthet Dermatol, V8, P38
[5]  
Moers-Carpi MM, 2013, DERMATOL SURG
[6]  
Sarasam A, 2004, P ANN BIOCH ENG S, V34